A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Pharmacology and Therapeutics

Volumn 125, Issue 1, 2010, Pages 27-38

  Cuadra, Adolfo E ^a   Shan, Zhiying ^a   Sumners, Colin ^a   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II type 1 receptor; Blood pressure; Hypertension; Signaling; Sympathetic; Tissue localized renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PRORENIN RECEPTOR; RENIN; RENIN INHIBITOR;

ADRENERGIC ACTIVITY; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; BRAIN FUNCTION; FEEDBACK SYSTEM; HUMAN; HYPERTENSION; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; HUMANS; HYPERTENSION; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 72149091180     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.07.007     Document Type: Review

References (186)

1. Allen A.M. Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge. J Renin Angiotensin Aldosterone Syst 2 (2001) s120-s124
2. Allen A.M., Dosanjh J.K., Erac M., Dassanayake S., Hannan R.D., and Thomas W.G. Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension 47 (2006) 1054-1061
3. Allen A.M., MacGregor D.P., McKinley M.J., and Mendelsohn F.A. Angiotensin II receptors in the human brain. Regul Pept 79 (1999) 1-7
4. Avantaggiato V., Pandolfi P.P., Ruthardt M., Hawe N., Acampora D., Pelicci P.G., et al. Developmental analysis of murine Promyelocyte Leukemia Zinc Finger (PLZF) gene expression: implications for the neuromeric model of the forebrain organization. J Neurosci 15 (1995) 4927-4942
5. Averill D.B., and Diz D.I. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 51 (2000) 119-128
6. Bader M., and Ganten D. It's renin in the brain: transgenic animals elucidate the brain renin-angiotensin system. Circ Res 90 (2002) 8-10
7. Bader M., Peters J., Baltatu O., Muller D.N., Luft F.C., and Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79 (2001) 76-102
8. Bakris G., Bursztyn M., Gavras I., Bresnahan M., and Gavras H. Role of vasopressin in essential hypertension: racial differences. J Hypertens 15 (1997) 545-550
9. Bankir L., Fernandes S., Bardoux P., Bouby N., and Bichet D.G. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16 (2005) 1920-1928
10. Bankir L., Perucca J., and Weinberger M.H. Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol 2 (2007) 304-312
11. Barnes K.L., DeWeese D.M., and Andresen M.C. Angiotensin potentiates excitatory sensory synaptic transmission to medial solitary tract nucleus neurons. Am J Physiol Regul Integr Comp Physiol 284 (2003) R1340-1353
12. Batenburg W.W., and Danser A.J. Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren. J Renin Angiotensin Aldosterone Syst 9 (2008) 181-184
13. Batenburg W.W., and Jan Danser A.H. The (pro)renin receptor: a new addition to the renin-angiotensin system?. Eur J Pharmacol 585 (2008) 320-324
14. Batenburg W.W., Krop M., Garrelds I.M., de Vries R., de Bruin R.J., Burckle C.A., et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 25 (2007) 2441-2453
15. Batenburg W.W., de Bruin R.J., van Gool J.M., Muller D.N., Bader M., Nguyen G., et al. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28 (2008) 1151-1157
16. Benarroch E.E. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 15 (2005) 254-263
17. Berridge M.J., and Irvine R.F. Inositol phosphates and cell signalling. Nature 341 (1989) 197-204
18. Bickerton R.K., and Buckley J.P. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med 106 (1961) 834-837
19. Bohlender J., Fukamizu A., Lippoldt A., Nomura T., Dietz R., Menard J., et al. High human renin hypertension in transgenic rats. Hypertension 29 (1997) 428-434
20. Boscan P., Allen A.M., and Paton J.F. Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract. Neuroscience 103 (2001) 153-160
21. Bourque C.W., and Renaud L.P. Activity patterns and osmosensitivity of rat supraoptic neurones in perfused hypothalamic explants. J Physiol 349 (1984) 631-642
22. Bundzikova J., Pirnik Z., Zelena D., Mikkelsen J.D., and Kiss A. Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats. Cell Mol Neurobiol 28 (2008) 1033-1047
23. Burckle C., and Bader M. Prorenin and its ancient receptor. Hypertension 48 (2006) 549-551
24. Burckle C.A., Jan Danser A.H., Muller D.N., Garrelds I.M., Gasc J.-M., Popova E., et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47 (2006) 552-556
25. Bursztyn M., Bresnahan M., Gavras I., and Gavras H. Pressor hormones in elderly hypertensive persons. Racial differences. Hypertension 15 (1990) I88-92
26. Cabassi A., Vinci S., Cantoni A.M., Quartieri F., Moschini L., Cavazzini S., et al. Sympathetic activation in adipose tissue and skeletal muscle of hypertensive rats. Hypertension 39 (2002) 656-661
27. Campbell D.J. Critical review of prorenin and (pro)renin receptor research. Hypertension 51 (2008) 1259-1264
28. Campbell D.J., Lawrence A.C., Towrie A., Kladis A., and Valentijn A.J. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18 (1991) 763-773
29. Chan S.H., Hsu K.S., Huang C.C., Wang L.L., Ou C.C., and Chan J.Y. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 97 (2005) 772-780
30. Chapleau M.W., and Abboud F.M. The baroreceptor reflex: novel methods and mechanisms. In: Dun N.J., Benedito H., and Pilowsky P.M. (Eds). Neural Mechanisms of Cardiovascular Regulation 1-29 (2004), Kluwer Academic Publishers, Norwell, MA
31. Cleland S.J., and Reid J.L. The renin-angiotensin system and the heart: a historical review. Heart 76 (1996) 7-12
32. Colombari E., Sato M.A., Cravo S.L., Bergamaschi C.T., Campos Jr. R.R., and Lopes O.U. Role of the medulla oblongata in hypertension. Hypertension 38 (2001) 549-554
33. Dampney R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74 (1994) 323-364
34. Das M., and Soffer R.L. Pulmonary angiotensin-converting enzyme antienzyme antibody. Biochemistry 15 (1976) 5088-5094
35. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 (2000) 415-472
36. de Wardener H.E. The hypothalamus and hypertension. Physiol Rev 81 (2001) 1599-1658
37. Doolittle R.F. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222 (1983) 417-419
38. Esler M. The sympathetic system and hypertension. Am J Hypertens 13 (2000) 99S-105S
39. Feldman D.L., Jin L., Xuan H., Contrepas A., Zhou Y., Webb R.L., et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension 52 (2008) 130-136
40. Feldt S., et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 51 (2008) 682-688
41. Feldt S., Maschke U., Dechend R., Luft F.C., and Muller D.N. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 19 (2008) 743-748
42. Ferrario C.M., and Strawn W.B. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98 (2006) 121-128
43. Fischer-Ferraro C., Nahmod V.E., Goldstein D.J., and Finkielman S. Angiotensin and renin in rat and dog brain. J Exp Med 133 (1971) 353-361
44. Francis J., Wei S.G., Weiss R.M., and Felder R.B. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H2138-2146
45. Ganten D., Hermann K., Bayer C., Unger T., and Lang R.E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 221 (1983) 869-871
46. Ganten D., Minnich J.L., Granger P., Hayduk K., Brecht H.M., Barbeau A., et al. Angiotensin-forming enzyme in brain tissue. Science 173 (1971) 64-65
47. Ganten D., Wagner J., Zeh K., Bader M., Michel J.B., Paul M., et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A 89 (1992) 7806-7810
48. Goc A., and Stachowiak M.K. Bovine tyrosine hydroxylase gene-promoter regions involved in basal and angiotensin II-stimulated expression in nontransformed adrenal medullary cells. J Neurochem 62 (1994) 834-843
49. Goldsmith S.R. Baroreceptor-mediated suppression of osmotically stimulated vasopressin in normal humans. J Appl Physiol 65 (1988) 1226-1230
50. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
51. Griendling K.K., and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132 (1998) 9-15
52. Guyenet P.G. The sympathetic control of blood pressure. Nat Rev Neurosci 7 (2006) 335-346
53. Guyton A.C. Blood pressure control-special role of the kidneys and body fluids. Science 252 (1991) 1813-1816
54. Gyurko R., Wielbo D., and Phillips M.I. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept 49 (1993) 167-174
55. Harding J.W., Yoshida M.S., Dilts R.P., Woods T.M., and Wright J.W. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. J Neurochem 46 (1986) 1292-1297
56. Hatae T., Takimoto E., Murakami K., and Fukamizu A. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem 131 (1994) 43-47
57. Helmer O.M. Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta. Am J Physiol 188 (1957) 571-577
58. Henrich W.L., McAllister E.A., Eskue A., Miller T., and Moe O.W. Renin regulation in cultured proximal tubular cells. Hypertension 27 (1996) 1337-1340
59. Hermann K., McDonald W., Unger T., Lang R.E., and Ganten D. Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. J Physiol (Paris) 79 (1984) 471-480
60. Hirooka Y., Potts P.D., and Dampney R.A.L. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res 772 (1997) 107
61. Hogarty D.C., Speakman E.A., Puig V., and Phillips M.I. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res 586 (1992) 289-294
62. Hu L., Zhu D.-N., Yu Z., Wang J.Q., Sun Z.-J., and Yao T. Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol 92 (2002) 2153-2161
63. Huang W., Xu C., Kahng K.W., Noble N.A., Border W.A., and Huang Y. Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am J Physiol Renal Physiol 294 (2008) F1287-1295
64. Huang Y., Noble N.A., Zhang J., Xu C., and Border W.A. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 72 (2007) 45-52
65. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69 (2006) 105-113
66. Hunt L.T., and Dayhoff M.O. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. Biochem Biophys Res Commun 95 (1980) 864-871
67. Ichihara A., and Kaneshiro Y. Response to cardiovascular effects of nonproteolytic activation of prorenin. Hypertension 48 (2006) e114
68. Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 114 (2004) 1128-1135
69. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47 (2006) 894-900
70. Ichihara A., Suzuki F., Nakagawa T., Kaneshiro Y., Takemitsu T., Sakoda M., et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 17 (2006) 1950-1961
71. Ingelfinger J.R., Zuo W.M., Fon E.A., Ellison K.E., and Dzau V.J. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85 (1990) 417-423
72. Ito S., and Sved A.F. Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am J Physiol 270 (1996) R1317-1323
73. Ito S., and Sved A.F. Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla. Am J Physiol Heart Circ Physiol 279 (2000) H2961-2966
74. Ito S., Hiratsuka M., Komatsu K., Tsukamoto K., Kanmatsuse K., and Sved A.F. Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 41 (2003) 744-750
75. Ito S., Komatsu K., Tsukamoto K., Kanmatsuse K., and Sved A.F. Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 40 (2002) 552-559
76. Ivins S., Pemberton K., Guidez F., Howell L., Krumlauf R., and Zelent A. Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 22 (2003) 3685-3697
77. Jan Danser A.H. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 35 (2003) 759
78. Jan Danser A.H., and Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension 46 (2005) 1069-1076
79. Jan Danser A.H., Batenburg W.W., and van Esch J.H. Prorenin and the (pro)renin receptor-an update. Nephrol Dial Transplant 22 (2007) 1288-1292
80. Kaneshiro Y., Ichihara A., Sakoda M., Takemitsu T., Nabi A.H., Uddin M.N., et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 18 (2007) 1789-1795
81. Kasparov S., and Teschemacher A.G. Altered central catecholaminergic transmission and cardiovascular disease. Exp Physiol 93 (2008) 725-740
82. Kimura S., Mullins J.J., Bunnemann B., Metzger R., Hilgenfeldt U., Zimmermann F., et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. Embo J 11 (1992) 821-827
83. Kobori H., Nangaku M., Navar L.G., and Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59 (2007) 251-287
84. Kumar A., Rassoli A., and Raizada M.K. Angiotensinogen gene expression in neuronal and glial cells in primary cultures of rat brain. J Neurosci Res 19 (1988) 287-290
85. Lavoie J.L., Cassell M.D., Gross K.W., and Sigmund C.D. Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension 43 (2004) 1116-1119
86. Lavoie J.L., Cassell M.D., Gross K.W., and Sigmund C.D. Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model. Physiol Genomics 16 (2004) 240-246
87. Lazartigues E., Dunlay S.M., Loihl A.K., Sinnayah P., Lang J.A., Espelund J.J., et al. Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res 90 (2002) 617-624
88. Leenen F.H., Ruzicka M., and Huang B.S. The brain and salt-sensitive hypertension. Curr Hypertens Rep 4 (2002) 129-135
89. Li D.P., Chen S.R., and Pan H.L. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23 (2003) 5041-5049
90. Li Y.W., and Guyenet P.G. Angiotensin II decreases a resting K+ conductance in rat bulbospinal neurons of the C1 area. Circ Res 78 (1996) 274-282
91. Li Z., and Ferguson A.V. Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol 265 (1993) R302-309
92. Lifton R.P., Gharavi A.G., and Geller D.S. Molecular mechanisms of human hypertension. Cell 104 (2001) 545-556
93. Lind R.W., Swanson L.W., and Ganten D. Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. Clin Exp Hypertens A 6 (1984) 1915-1920
94. Lippoldt A., Fuxe K., and Luft F.C. A view of renin in the brain. J Mol Med 79 (2001) 71-73
95. Liu F., Brezniceanu M.L., Wei, C.C., Chenier I., Sachetelli S., Zhang S.L., et al. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 19 (2008) 269-280
96. Lu D., Yang H., Lenox R.H., and Raizada M.K. Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J Cell Biol 142 (1998) 217-227
97. Lu D., Yang H., and Raizada M.K. Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase. J Cell Biol 135 (1996) 1609-1617
98. Lu D., Yang H., and Raizada M.K. AT1 receptor-mediated nuclear translocation of Raf-1 in brain neurons. J Neurochem 70 (1998) 424-427
99. Lu D., Yu K., Paddy M.R., Rowland N.E., and Raizada M.K. Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology 137 (1996) 763-772
100. Luetscher J.A., Kraemer F.B., Wilson D.M., Schwartz H.C., and Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 312 (1985) 1412-1417
101. Luft F.C. Vasopressin, urine concentration, and hypertension: a new perspective on an old story. Clin J Am Soc Nephrol 2 (2007) 196-197
102. Macrez N., Mironneau C., Carricaburu V., Quignard J.F., Babich A., Czupalla C., et al. Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca(2+) channels. Circ Res 89 (2001) 692-699
103. Mason W.T. Supraoptic neurones of rat hypothalamus are osmosensitive. Nature 287 (1980) 154-157
104. McKinley M.J., Allen A.M., Mathai M.L., May C., McAllen R.M., Oldfield B.J., et al. Brain angiotensin and body fluid homeostasis. Jpn J Physiol 51 (2001) 281-289
105. Mercure C., Thibault G., Lussier-Cacan S., Davignon J., Schiffrin E.L., and Reudelhuber T.L. Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem 270 (1995) 16355-16359
106. Merrill D.C., Thompson M.W., Carney C.L., Granwehr B.P., Schlager G., Robillard G.E., et al. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97 (1996) 1047-1055
107. Milsted A., Barna B.P., Ransohoff R.M., Brosnihan K.B., and Ferrario C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci U S A 87 (1990) 5720-5723
108. Moe O.W., Ujiie K., Star R.A., Miller R.T., Widell J., Alpern R.J., et al. Renin expression in renal proximal tubule. J Clin Invest 91 (1993) 774-779
109. Morimoto S., and Sigmund C.D. Angiotensin mutant mice: a focus on the brain renin-angiotensin system. Neuropeptides 36 (2002) 194-200
110. Morimoto S., Cassell M.D., and Sigmund C.D. The brain renin-angiotensin system in transgenic mice carrying a highly regulated human renin transgene. Circ Res 90 (2002) 80-86
111. Muller D.N., Bohlender J., Hilgers K.F., Dragun D., Costerousse O., Menard J., et al. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 29 (1997) 98-104
112. Muller D.N., Hilgers K.F., Bohlender J., Lippoldt A., Wagner J., Fischli W., et al. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. Hypertension 26 (1995) 272-278
113. Muller D.N., Klanke B., Feldt S., Cordasic N., Hartner A., Schmieder R.E., et al. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 51 (2008) 676-681
114. Mullins J.J., Peters J., and Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344 (1990) 541-544
115. Nabi A.H., Kageshima A., Uddin M.N., Nakagawa T., Park E.Y., and Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 18 (2006) 483-488
116. Nakamura S., Moriguchi A., Morishita R., Yamada K., Nishii T., Tomita N., et al. Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats. Hypertension 34 (1999) 302-308
117. Nguyen G. Renin/prorenin receptors. Kidney Int 69 (2006) 1503
118. Nguyen G., and Contrepas A. Physiology and pharmacology of the (pro)renin receptor. Curr Opinion Pharmacol 8 (2008) 127
119. Nguyen G., and Contrepas A. The (pro)renin receptors. J Mol Med 86 (2008) 643-646
120. Nguyen G., Delarue F., Berrou J., Rondeau E., and Sraer J.-D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50 (1996) 1897
121. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109 (2002) 1417-1427
122. Nishii T., Moriguchi A., Morishita R., Yamada K., Nakamura S., Tomita N., et al. Angiotensinogen gene-activating elements regulate blood pressure in the brain. Circ Res 85 (1999) 257-263
123. Nurun N.A., Uddin N.M., Nakagawa T., Iwata H., Ichihara A., Inagami T., et al. Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci 12 (2007) 4810-4817
124. Obermuller N., Unger T., Culman J., Gohlke P., de Gasparo M., and Bottari S.P. Distribution of angiotensin II receptor subtypes in rat brain nuclei. Neurosci Lett 132 (1991) 11-15
125. Pan H.L. Brain angiotensin II and synaptic transmission. Neuroscientist 10 (2004) 422-431
126. Paul M., Wagner D., Metzger R., Ganten D., Lang R.E., Suzuki F., et al. Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay. J Hypertens 6 (1988) 247-252
127. Phillips M.I., and Kimura B. Brain angiotensin in the developing spontaneously hypertensive rat. J Hypertens 6 (1988) 607-612
128. Phillips M.I., Mann J.F., Haebara H., Hoffman W.E., Dietz R., Schelling P., et al. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature 270 (1977) 445-447
129. Phillips M.I., Shen L., Richards E.M., and Raizada M.K. Immunohistochemical mapping of angiotensin AT1 receptors in the brain. Regul Pept 44 (1993) 95-107
130. Pickel V.M., and Chan J. Co-localization of angiotensin II and gamma-aminobutyric acid in axon terminals in the rat subfornical organ. Neurosci Lett 193 (1995) 89-92
131. Pickel V.M., Chan J., and Ganten D. Dual peroxidase and colloidal gold-labeling study of angiotensin converting enzyme and angiotensin-like immunoreactivity in the rat subfornical organ. J Neurosci 6 (1986) 2457-2469
132. Ramser J., Abidi F.E., Burckle C.A., Lenski C., Toriello H., Wen G., et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 14 (2005) 1019-1027
133. Rao G.N., and Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70 (1992) 593-599
134. Reaux A., Fournie-Zaluski M.C., and Llorens-Cortes C. Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab 12 (2001) 157-162
135. Richoux J.P., Bouhnik J., Clauser E., and Corvol P. The renin-angiotensin system in the rat brain. Immunocytochemical localization of angiotensinogen in glial cells and neurons. Histochemistry 89 (1988) 323-331
136. Ruiz P., Basso N., Cannata M.A., and Taquini A.C. The renin-angiotensin system in different stages of spontaneous hypertension in the rat (S H R). Clin Exp Hypertens A 12 (1990) 63-81
137. Saavedra J.M. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25 (2005) 485-512
138. Sakai K., Agassandian K., Morimoto S., Sinnayah P., Cassell M.D., Davisson R.L., et al. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest 117 (2007) 1088-1095
139. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99 (2006) 1355-1366
140. Schefe J.H., Unger T., and Funke-Kaiser H. PLZF and the (pro)renin receptor. J Mol Med 86 (2008) 623-627
141. Schinke M., Baltatu O., Bohm M., Peters J., Rascher W., Bricca G., et al. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A 96 (1999) 3975-3980
142. Schlaich M.P., Lambert E., Kaye D.M., Krozowski Z., Campbell D.J., Lambert G., et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43 (2004) 169-175
143. Seo H., Yang C., Kim H.S., and Kim K.S. Multiple protein factors interact with the cis-regulatory elements of the proximal promoter in a cell-specific manner and regulate transcription of the dopamine beta-hydroxylase gene. J Neurosci 16 (1996) 4102-4112
144. Shan Z., Cuadra A.E., Lin F., Sumners C., and Raizada M.K. Increased expression of (pro)renin receptor in the brain from spontaneously hypertensive rats. Paper presented at: 62 High Blood Pressure Research Conference. (Alanta, GA) (2008)
145. Shan Z., Cuadra A.E., Sumners C., and Raizada M.K. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol 93 (2008) 701-708
146. Sinnayah P., Lazartigues E., Sakai K., Sharma R.V., Sigmund C.D., and Davisson R.L. Genetic ablation of angiotensinogen in the subfornical organ of the brain prevents the central angiotensinergic pressor response. Circ Res 99 (2006) 1125-1131
147. Skeggs Jr. L.T., Kahn J.R., and Shumway N.P. The preparation and function of the hypertensin-converting enzyme. J Exp Med 103 (1956) 295-299
148. Smith P.R., Stoner L.C., Viggiano S.C., Angelides K.J., and Benos D.J. Effects of vasopressin and aldosterone on the lateral mobility of epithelial Na+ channels in A6 renal epithelial cells. J Membr Biol 147 (1995) 195-205
149. Steinberg S.F. PI3King the L-type calcium channel activation mechanism. Circ Res 89 (2001) 641-644
150. Stornetta R.L., Hawelu-Johnson C.L., Guyenet P.G., and Lynch K.R. Astrocytes synthesize angiotensinogen in brain. Science 242 (1988) 1444-1446
151. Sun C., Sellers K.W., Sumners C., and Raizada M.K. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96 (2005) 659-666
152. Sun C., Sumners C., and Raizada M.K. Chronotropic action of angiotensin II in neurons via protein kinase C and CaMKII. Hypertension 39 (2002) 562-566
153. Suzuki F., Hayakawa M., Nakagawa T., Nasir U.M., Ebihara A., Iwasawa A., et al. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Chem 278 (2003) 22217-22222
154. Swanson L.W., and Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6 (1983) 269-324
155. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50 (2001) 537-546
156. Tagawa T., Fontes M.A., Potts P.D., Allen A.M., and Dampney R.A. The physiological role of AT1 receptors in the ventrolateral medulla. Braz J Med Biol Res 33 (2000) 643-652
157. Tagawa T., Horiuchi J., Potts P.D., and Dampney R.A. Sympathoinhibition after angiotensin receptor blockade in the rostral ventrolateral medulla is independent of glutamate and gamma-aminobutyric acid receptors. J Auton Nerv Syst 77 (1999) 21-30
158. Takahashi H., Ichihara A., Kaneshiro Y., Inomata K., Sakoda M., Takemitsu T., et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 18 (2007) 2054-2061
159. Takeda K., and Bunag R.D. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 2 (1980) 97-101
160. Tamura K., Umemura S., Nyui N., Yamakawa T., Yamaguchi S., Ishigami T., et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 27 (1996) 1216-1223
161. Tan J., Wang H., and Leenen F.H. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286 (2004) H1665-1671
162. Thomas W.G., Greenland K.J., Shinkel T.A., and Sernia C. Angiotensinogen is secreted by pure rat neuronal cell cultures. Brain Res 588 (1992) 191-200
163. Treschan T.A., and Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology 105 (2006) 599-612 quiz 639-540
164. Trolliet M.R., and Phillips M.I. The effect of chronic bilateral nephrectomy on plasma and brain angiotensin. J Hypertens 10 (1992) 29-36
165. Tsutsumi K., and Saavedra J.M. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 261 (1991) R209-216
166. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273 (1998) 15022-15029
167. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274 (1999) 22699-22704
168. Ushio-Fukai M., Griendling K.K., Akers M., Lyons P.R., and Alexander R.W. Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. J Biol Chem 273 (1998) 19772-19777
169. Vanhaesebroeck B., and Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253 (1999) 239-254
170. Vanhaesebroeck B., Leevers S.J., Panayotou G., and Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 22 (1997) 267-272
171. Veerasingham S.J., and Raizada M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139 (2003) 191-202
172. Veltmar A., Culman J., Qadri F., Rascher W., and Unger T. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther 263 (1992) 1253-1260
173. Veniant M., Menard J., Bruneval P., Morley S., Gonzales M.F., and Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 98 (1996) 1966-1970
174. Viard P., Butcher A.J., Halet G., Davies A., Nurnberg B., Heblich F., et al. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 7 (2004) 939-946
175. Viard P., Exner T., Maier U., Mironneau J., Nurnberg B., and Macrez N. Gbetagamma dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase. Faseb J 13 (1999) 685-694
176. Wei S.G., and Felder R.B. Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 282 (2002) H890-895
177. Weyhenmeyer J.A., and Phillips M.I. Angiotensin-like immunoreactivity in the brain of the spontaneously hypertensive rat. Hypertension 4 (1982) 514-523
178. Yamazato M., Yamazato Y., Sun C., Diez-Freire C., and Raizada M.K. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49 (2007) 926-931
179. Yang H., and Raizada M.K. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci 19 (1999) 2413-2423
180. Yang H., Lu D., Yu K., and Raizada M.K. Regulation of neuromodulatory actions of angiotensin II in the brain neurons by the Ras-dependent mitogen-activated protein kinase pathway. J Neurosci 16 (1996) 4047-4058
181. Yang H., Shaw G., and Raizada M.K. ANG II stimulation of neuritogenesis involves protein kinase B in brain neurons. Am J Physiol Regul Integr Comp Physiol 283 (2002) R107-114
182. Yang H., Wang X., and Raizada M.K. Characterization of signal transduction pathway in neurotropic action of angiotensin II in brain neurons. Endocrinology 142 (2001) 3502-3511
183. Yongue B.G., Angulo J.A., McEwen B.S., and Myers M.M. Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats. Hypertension 17 (1991) 485-491
184. Yu K., Lu D., Paddy M.R., Lenk S.E., and Raizada M.K. Angiotensin II regulation of plasminogen activator inhibitor-1 gene expression in neurons of normotensive and spontaneously hypertensive rat brains. Endocrinology 137 (1996) 2503-2513
185. Zhang S.L., To C., Chen X., Filep J.G., Tang S.S., Ingelfinger J.R., et al. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells. Exp Nephrol 9 (2001) 109-117
186. Zhu M., Neubig R.R., Wade S.M., Posner P., Gelband C.H., Sumners C., et al. Modulation of K+ and Ca2+ currents in cultured neurons by an angiotensin II type 1a receptor peptide. Am J Physiol 273 (1997) C1040-1048